Author:
Kouhen Fadila,Sqali Houssaini Mohammed
Reference4 articles.
1. Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial;Monk;Lancet Oncol,2023
2. A randomised phase 3 trial of induction chemotherapy followed by chemoradiation compared with chemoradiation alone in locally advanced cervical cancer: the GCIG INTERLACE trial. ESMO Congress 2023, LBA8;McCormack;Ann Oncol,2023
3. Durable benefit and the potential for long-term survival with immunotherapy in advanced melanoma;McDermott;Cancer Treat Rev,2014
4. HPV-positive and negative cervical cancers are immunologically distinct;Evans;J Clin Med,2022